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Background. While asymptomatic patients should have a lower risk of cardiac events
compared to symptomatic patients referred for cardiac stress testing, comparable event rates
have been noted in some prior prognostic studies. To test if a high burden of undetected
atherosclerosis among asymptomatic patients helps explain such ﬁndings, we compared ath-
erosclerotic burden, as measured by coronary artery calcium (CAC) scanning, in propensity-
matched groups of volunteers and asymptomatic patients.
Methods. CAC scans were performed on a research basis in 136 asymptomatic patients
referred for exercise myocardial perfusion SPECT and in 1,398 volunteers. We performed
matching by propensity scores to compare volunteers with the same CAD risk factor proﬁle as
our asymptomatic patients.
Results. Among our matched groups, asymptomatic patients had signiﬁcantly greater mean
CAC scores than volunteers (394 ± 805 vs 151 ± 349, P 5 .001), primarily due to a higher
frequency of CAC scores >1,000 (15.4% vs 2.5%, P < .001). Inducible myocardial ischemia by
SPECT was present in 7% of patients, but was selectively concentrated among those with CAC
scores >1,000, occurring in 27.0% of such patients vs only 1.9% among patients with CAC
scores <1,000 (P < .0001).
Conclusions. In contrast to asymptomatic volunteers, asymptomatic patients referred for
cardiac stress testing possess more extensive atherosclerosis as measured by CAC. Among
asymptomatic patients with high CAC scores, the frequency of concomitant inducible myo-
cardial ischemia is high. These results help explain prior prognostic studies concerning
asymptomatic patients and indicate the importance of making a clinical distinction between
healthy subjects and asymptomatic patients with respect to atherosclerotic risk. (J Nucl Cardiol
2011;18:291–8.)
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INTRODUCTION
Because approximately half of men and women
experiencingsuddencardiacdeathdosowithoutanyprior
clinical symptoms,
1 how to best identify asymptomatic
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291patients who are at risk for future cardiac events is an
important medical issue. A Bayesian approach for the
identiﬁcation of CAD risk was initially developed by
DiamondandForrester,
2basedonpatients’age,sex,chest
pain symptoms, and consideration of patients’ CAD risk
factors. Because middle aged and older asymptomatic
patients with multiple CAD risk factors may have an
intermediate ([15%) Bayesian likelihood of CAD, they
are not uncommonly referred for cardiac stress testing.
3
Patients presenting with chest pain symptoms have an
even higher Bayesian likelihood of CAD, which should
thus place such patients at even higher risk for future
cardiac events.
4 Notably, however, comparisons of out-
comes among patients with and without chest pain
syndromes that have been referred for cardiac stress have
revealed comparable event rates in some studies.
5-7
Heretofore, an explanation for these ﬁndings has been
lacking. One possibility is that asymptomatic patients
referred for cardiac stress testing may have a greater than
suspectedburdenofsubclinicalatherosclerosisthatplaces
such patients at increased risk for cardiac events. New
technologies such as coronary artery calcium (CAC)
scanning allow us to test this hypothesis. Accordingly, in
this study, we compared the presence and magnitude of
subclinicalatherosclerosis,asmeasuredbyCACscanning
in a cohort of asymptomatic patients referred for cardiac




The participants of this study included 136 asymptomatic
patients (i.e., without chest pain symptoms), with a mean age
of 59.2 ± 10.0, who were referred for exercise myocardial
perfusion scintigraphy (MPS) at Cedars Sinai Medical Center
(CSMC) by their referring physicians. These clinically referred
patients underwent additional CAC scanning on a prospective
research basis. Asymptomatic patients complaining of dyspnea
were excluded,
6 as were those with known CAD, cardiomy-
opathy, valvular disease, or those requiring pharmacologic
stress testing. We separately evaluated a community cohort of
1,397 healthy asymptomatic volunteers who were recruited as
part of a trial to assess the long-term impact of CAC scanning
on subjects’ health behaviors and risk proﬁles, the Early
Identiﬁcation of Subclinical Atherosclerosis by Noninvasive
Imaging Research (EISNER) trial. We preferentially recruited
males, 45-80 years, or females 55-80 years, with one or more
CAD risk factors. These volunteers underwent CAC scanning
but not MPS. This research was approved by the CSMC
Institutional Review Board and all subjects signed informed
consent.
Clinical Information
At the time of testing, all patients completed a question-
naireregardingdemographicinformation,chestpainsymptoms,
cardiac risk factors, and medication use. A Bayesian pre-MPS
likelihood of CAD was calculated for each patient based on the
analysis of age, gender, risk factors, chest pain symptoms, and
results of exercise electrocardiography according to a previ-
ously validated commercial program (CADENZA).
8 Fasting
blood samples were obtained to assess total cholesterol, HDL
cholesterol, and triglycerides, with calculated LDL cholesterol
values. Serum glucose levels were assessed by a Cholestech
(Hayward, CA, USA) desktop chemical analyzer. Weight and
height were obtained on each subject for calculation of body
mass index (BMI). Using the clinical and serum measures, a
Framingham 10-year risk of cardiac death or nonfatal myocar-
dial infarction was calculated for each subject in accordance
with published guidelines.
9
Stress Testing and Imaging Protocol
Following symptom-limited Bruce protocol exercise,
patients underwent separate-acquisition-gated dual isotope
MPSaspreviouslydescribed,
10withthallium-201(3.0-4.5 mCi)
injected at rest and technetium-99m sestamibi (25-40 mCi)
injectedatnear maximalexercise.Anelliptical 180acquisition
and standard energy windows were used. Semi-quantitative
visual interpretation was performed by experienced observers
using a 5-point score for each of 20 myocardial segments and





Scanning was performed using either electron beam
computed tomography (EBT) (Imatron C-150 or GE e-Speed)
or multispiral computed tomography (MSCT) (Siemens Vol-
ume Zoom, Siemens Medical Systems). Each patient’s scan
consisted of approximately 30-40 slices of 3 or 2.5 mm for EBT
and MSCT, respectively, with triggering at 50%-80% of the
cardiac cycle. Foci of CAC were identiﬁed by an experienced
technologist and scored using semi-automatic commercial
software by detection of at least three contiguous pixels (voxel
size = 1.03 mm
3) of peak density C 130 Hounsﬁeld units
within a coronary artery. CAC scores were calculated according
to the method of Agatston et al
11 Percentage CAC scores, based




Continuous variables were expressed as mean ± standard
deviation and were compared using two-sample t-tests for
normal data and two-sample Wilcoxon rank-sum test for
nonnormal data. Normality was assessed by using Shapiro-
Francia, Shapiro–Wilk, and Skewness/Kurtosis tests for nor-
mality. Because the distribution of CAC scores are highly
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toward normality in the form of log(CAC ? 1) was also used
(adding one to deal with the 0 scores). Categorical variables
were compared using the Pearson v
2 test; the v
2 test for trend
and Fisher Exact test for cell counts\6 were also used where
appropriate. In order to adjust for differences in baseline
characteristics between subjects and patients, all 136 were
matched to the volunteer subjects on a 2:1 volunteer to patient
ratio on the basis of age, gender, BMI, and history of the
following coronary risk factors: high cholesterol, hypertension,
smoking, diabetes, and family history of premature CAD.
Matching was done using propensity scores that were derived
from the predicted probabilities that resulted from a logistic
regression model to predict being a patient vs being a sub-
ject.
13 Since the matching was 2:1, the propensity matched
groups were also compared as described above.
RESULTS
Baseline Characteristics
A comparison of the clinical characteristics among
the two study groups is shown in Table 1. The healthy
volunteers and patients were comparable in age but there
were a greater percentage of males among the patients.
The patient group had a higher frequency of high cho-
lesterol, hypertension, diabetes, and higher glucose
levels. Serum cholesterol and LDL levels were lower but
lipid-lowering usage was greater among the patient
cohort. Overall, all but 11 (8%) of our patient cohort had
the presence of C1 CAD risk factors and 96 (71%) had
C2 CAD risk factors.






(N 5 136) P-values
Age 58.6 ± 8.6 59.2 ± 10.0 .41
Male 739 (52.9%) 104 (76.5%) \.001
CAD risk factors
High cholesterol 817 (58.4%) 100 (73.5%) .001
Hypertension 583 (41.7%) 74 (54.4%) .004
Smoking 91 (6.5%) 11 (8.1%) .48
Diabetes 92 (6.6%) 22 (16.2%) \.001
Family history 382 (27.3%) 35 (25.7%) .69
# of CAD risk factors 1.4 ± 0.9 1.7 ± 1.0 \.0001
BMI 27.7 ± 5.3 28.2 ± 5.3 .09
Pre-test likelihood of CAD 6.7 ± 4.0 7.9 ± 4.7 .001
Medication use
Blood pressure medications 450 (32.2%) 59 (43.4%) .008
Lipid lowering medications 364 (26.0%) 56 (41.2%) \.001
Laboratory values
Glucose 96.1 ± 19.0 101.2 ± 29.4 .005
Cholesterol 215.4 ± 41.6 203.0 ± 47.6 .0001
LDL 135.6 ± 38.9 124.1 ± 41.7 .0002
HDL 53.8 ± 16.6 51.5 ± 16.2 .12
Triglycerides 133.9 ± 84.4 135.7 ± 104.3 .35
FRS
Mean score 11.0 ± 7.0 13.0 ± 8.2 .01
FRS\%10 618 (56.0%) 48 (42.9%)
FRS 10%–20% 319 (28.9%) 37 (33.0%)
FRS[20% 167 (15.1%) 27 (24.1%) .01
Resting hemodynamic
Heart rate (bpm) 66.3 ± 10.3 67.8 ± 12.1 0.22
Systolic BP (mmHg) 133.1 ± 17.5 135.3 ± 16.0 0.06
Diastolic BP (mmHg) 82.0 ± 10.7 80.0 ± 8.0 0.005
BP, Blood pressure.
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Asymptomatic Groups
Table 2 lists the CAC ﬁndings in the two study
groups. The mean CAC score was more than twofold
higher in the patient group. More volunteers than
patients had normal CAC scans and conversely, there
was a substantially greater frequency of patients with
very high CAC scores (i.e., [1,000) compared to the
volunteer group: 15.4% vs 2.9%, P\.001. Similarly,
the mean percentile CAC score was higher in the patient
group and more patients than volunteers had a CAC
percentile score C90%, P = .002.
Stress Test and Rest ECG Findings Among
the Asymptomatic Patients
Among the 136 patients, the mean exercise duration
was 9.6 ± 2.8 min, with a mean peak heart rate of 155 ±
13 bpm and mean peak systolic/diastolic blood pressure
of173/77 mmHg.AnischemicSPECTstudywasnotedin
9 (7%) of the 136 patients, and in these patients, the mean
CAC score was signiﬁcantly higher than in the nonis-
chemic SPECT patients (1616 ± 1182 vs 307 ± 700,
P\.0001). An ischemic SPECT occurred in only 2
(1.9%) of the patients with a CAC score\1,000 but in 7
(27.0%) of the 26 patients with a CAC score C1,000
(P\.0001).
Forty-ﬁve (33%) of the 136 patients had an abnor-
mal ECG response during exercise testing, but of these
45, 42 (93%) had a normal exercise SPECT study, and
the mean CAC score was not signiﬁcantly different
among the 42 nonischemic SPECT patients with an
abnormal exercise ECG response vs the 88 nonischemic
SPECT patients with a normal exercise ECG response
(355 ± 581 vs 275 ± 755, P = .56).
We also repeated our analyses after excluding all
patientsmanifestinganabnormalexerciseECGresponse.
The substantial difference in mean CAC scores persisted
in the remaining 91 asymptomatic patients compared to
the healthy volunteers (385 ± 890 vs 122 ± 347, P\
.0001)asdidthepercentwithCACscores[1,000(13.2%
vs 2.5%, P\.0001).
Among the 136 referred patients, 40 (29%) had an
abnormal rest ECG as an indicated reason for testing.
The mean CAC score in this group was also not higher
compared to those patients who had a normal resting
ECG (279 ± 734 vs 413 ± 829, P\.10). Other reasons
for patient referral varied widely, including the referral
of nine patients (7%) for pre-operative evaluation.
Comparison of the Volunteer and Patients
Groups Following Propensity Analysis
Following a 2:1 propensity matching of the volun-
teer and patient groups on the basis of age, gender, and
each of the major CAD risk factors (hypercholesterol-
emia, hypertension, smoking, diabetes, family history,
and BMI), there were 272 propensity-matched volun-
teers and 136 propensity-matched patients. As shown in
Table 3, these two groups manifested no signiﬁcant
differences in age, gender distribution, CAD risk factors,
medication use, Framingham risk score (FRS) scores, or
pre-test likelihood of CAD. Serum chemistries differed
only slightly (mildly lower cholesterol, LDL, and
triglyceride values in the patient cohort).









(N 5 136) P-values
Mean CAC score 122 ± 347 394 ± 805 \.0001
Mean log CAC score 2.2 ± 2.4 3.5 ± 2.8 \.0001
Distribution of CAC scores
CAC = 0 664 (47.5%) 42 (30.9%)
CAC 10–99 416 (29.7%) 37 (27.2%)
CAC 100–399 196 (14.0%) 25 (18.4%)
CAC 400–999 87 (6.2%) 11 (8.1%)
CAC C 1000 35 (2.5%) 21 (15.4%) \.001
CAC percentile 33.2 ± 35.8 47.3 ± 37.9 \.0001
CAC\50th percentile 873 (62.5%) 66 (48.5%)
CAC 50–74th percentiles 257 (18.4%) 25 (18.4%)
CAC 75–89th percentiles 160 (11.4%) 19 (14.0%)
CAC C 90th percentile 108 (7.7%) 26 (19.1%) \.001
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remained signiﬁcantly higher in the patient group com-
paredtothehealthyvolunteers(Table 4).Thisdifferencein
mean CAC scores within the propensity-matched sub-
groups was again due to a signiﬁcantly greater percentage
of patients with CAC scores[1,000 compared to propen-
sity-matched healthy volunteers (Figure 1).
DISCUSSION
In this study, asymptomatic patients who were rou-
tinely referred for stress–rest myocardial perfusion
SPECT were compared to a large group of asymptomatic
individuals, recruited on a research basis as part of the
EISNER study. In neither group was coronary calcium
scanning used to determine the selection of subjects for
study. Despite the absence of chest pain in both groups,
the asymptomatic patients had a substantially greater
mean CAC score, reﬂecting greater underlying athero-
sclerosis. This difference was due to a substantially
greater concentration of patients with high CAC scores
among the patient group. Nearly one-fourth of the
asymptomatic patients had CAC scores[400 and *15%
had CAC scores[1,000. By contrast,\3% of compara-
bly aged healthy volunteers had CAC scores[1,000.
Since the asymptomatic stress test patients were
older, contained more males, and had a substantially
greater frequency of CAD risk factors, we performed
propensity matching to deﬁne a subgroup of volunteers
and patients with the same risk factor proﬁle. Because
of our large volunteer population, we were able to
perform this matching without excluding any patients.
Among the propensity-matched subgroups, the greater
frequency of patients with severe CAC scores ([1,000)
persisted among the patients compared to their matched
controls.




patients (N 5 136) P-values
Age
a 58.5 ± 9.1 59.2 ± 10.0 .43
Male
a 207 (76.1%) 104 (76.5%) .93
CAD risk factors
High cholesterol
a 198 (72.8%) 100 (73.5%) .88
Hypertension
a 168 (61.8%) 74 (54.4%) .15
Smoking
a 14 (5.2%) 11 (8.1%) .24
Diabetes
a 40 (14.7%) 22 (16.2%) .70
Family history
a 64 (23.5%) 35 (25.7%) .62
# of CAD factors 1.8 ± 0.9 1.7 ± 1.0 .82
BMI
a 28.4 ± 5.1 28.2 ± 5.3 .65
Medication use
Blood pressure medications 123 (45.2%) 59 (43.4%) .73
Lipid lowering medications 99 (36.4%) 56 (41.2%) .35
Laboratory values
Glucose 100.6 ± 22.4 101.2 ± 29.4 .67
Cholesterol 211.5 ± 43.6 203.0 ± 47.6 .03
LDL 133.6 ± 39.5 124.1 ± 41.7 .01
HDL 50.4 ± 16.5 51.5 ± 16.2 .32
Triglycerides 140.9 ± 87.2 135.7 ± 104.3 .05
FRS
Mean score 13.9 ± 8.3 13.0 ± 8.2 .35
FRS\10% 89 (42.8%) 48 (42.9%)
FRS 10%–20% 61 (29.3%) 37 (33.0%)
FRS[20% 58 (27.9%) 27 (24.1%) .70
Resting hemodynamics
Heart rate (bpm) 66.5 ± 10.6 67.8 ± 12.1 .39
Systolic BP (mmHg) 137.1 ± 17.2 135.3 ± 16.0 .50
Diastolic BP (mmHg) 85.8 ± 11.2 80.0 ± 8.0 \.0001
a Propensity-matched on these clinical risk factors.
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are commonly referred for exercise SPECT because of an
ischemic-appearing ECG response during treadmill
exercise. In our study, approximately one-third of our
asymptomatic patients had such abnormal responses.
However, 93% of these abnormal ECG responses were
associated with a normal exercise SPECT study, indi-
cating that they probably represented false positive
response forinducible myocardial ischemia in our patient
population. We foundthat the magnitude of CAC was not
signiﬁcantly different among the nonischemic SPECT
subgroups that manifested a normal vs abnormal ECG
response during exercise testing. Moreover, excluding
all patients with a positive exercise ECG response to
exercise did not change the results of our study. Thus,
other factors must be operative to explain our ﬁndings.
Potential Explanations for Increased
Atherosclerosis in Asymptomatic
Patients
Various mechanisms may have potentially contrib-
uted to the increased atherosclerosis among our asymp-
tomatic patients. Potentially, our patients could have had
increased severity of CAD risk factors, including a more
severe family history of premature CAD. Alternatively,
the chronicity of CAD risk factors could have been
greater within our patient population. These potentially
important data were not obtained in our study. In addi-
tion, other CAD factors not analyzed in our data could
have served as intangible causes for increased cardiac
risk, such as increase in Lp(a), small dense LDL,
or homocysteine measurements. In addition, various
noncoronary disease processes that help promote more
fatigue, tension, and other somatic complaints that lead
to physician visits could be preferentially operative in
patient populations, including a higher frequency of
inﬂammatory diseases such as arthritis and autoimmune
disease,
14,15 and more chronic stress or depression.
These common conditions have been linked to various
pathophysiological mechanisms that may interact syn-
ergistically with conventional CAD risk factors
to promote accelerated atherosclerosis in patients.
16,17
Prospective study is needed to assess these and other
potential explanations for our ﬁndings.






(N 5 136) P-values
Mean CAC score 152 ± 349 394 ± 805 .001
Distribution of CAC scores
CAC = 0 111 (40.8%) 42 (30.9%)
CAC 1-9 24 (8.8%) 9 (6.6%)
CAC 10-99 63 (23.2%) 28 (20.6%)
CAC 100-399 34 (12.5%) 25 (18.4%)
CAC 400-999 32 (11.8%) 11 (8.1%)
CAC C 1000 8 (2.9%) 21 (15.4%) \.001
CAC percentile 35.6 ± 35.4 47.3 ± 37.9 .002
CAC\50th percentile 165 (60.7%) 66 (48.5%)
CAC 50–74th percentiles 55 (20.2%) 25 (18.4%)
CAC 75–89th percentile 29 (10.7%) 19 (14.0%)












Frequency of high (>1,000) CAC scores
Asymptomatic 
patients
Figure 1. Frequency of CAC scores [1,000 (y-axis) among
the 272 propensity-matched asymptomatic volunteers and 136
asymptomatic patients. A substantially greater frequency of
CAC scores[1,000 was noted within the patient group.
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Studies in Stress Test Populations
Among patients studied by planar thallium imaging
in the 1980s,
5 and then subsequently with SPECT imag-
ing in the 1990s,
6 we noted that asymptomatic patients
had cardiac event rates which were comparable to
patients with chest pain symptoms. Christopher Jones
et al
7 have noted similar ﬁndings among their stress test
patients. In other study, we have observed that asymp-
tomatic patients have a frequency of inducible myocar-
dial ischemia that is comparable to that observed among
symptomatic patients referred for stress testing.
10 Our
current ﬁndings suggest that a potential reason for these
prior observations is the existence of clinically silent but
substantial atherosclerotic burden among some asymp-
tomatic patients. The higher risk of this subgroup is fur-
ther suggested by our observation of a high rate of
inducible myocardial ischemia in over one-fourth of our
patients with CAC scores [1,000. Of note, in prior
studies involving a mixed cohort of patients with and
without chest pain symptoms, a CAC score [400 has
been noted to serve as a threshold for observingincreased
myocardial ischemia,
18,19 but pending further study,
perhaps the CAC score threshold for ischemia may be
higher in asymptomatic patients compared to those with
chest pain symptoms.
Limitations
Since our patient population was predominantly
male, the role of gender could not be assessed in our
study, nor did we assess the role of socioeconomic status
or psychosocial risk factors. In addition, as aforemen-
tioned, knowledge concerning the temporal duration as
well as the intensity of CAD risk factors may have been
relevant to our results and would be useful parameters to
assess in prospective studies comparing the presence and
magnitude of coronary risk factors to measurements of
atherosclerosis.
Clinical Relevance
Multiple potential means exist for screening asymp-
tomatic patients, including the use of global algorithms
such as the FRS, Bayesian analysis of CAD likelihood,
the use of cardiac stress testing, and more recently, the
application of CAC scanning. Recent study has deﬁned
limitations of relying on the FRS score to screen for
underlying CAD
20 and in our study there was no dif-
ference between FRS in our matched volunteers and
asymptomatic patients, despite the presence of more
atherosclerosis in the latter group. Similarly, a limitation
to Bayesian analysis is that it was developed for the
prediction of angiographically signiﬁcant CAD (i.e.,
[50% cross-luminal narrowing) and thus may not be a
good predictor of atherosclerosis, per se. Indeed, the
Bayesian likelihood of CAD was also comparable in our
matched volunteers and patients. Also pointing to the
limitation of Bayesian analysis for screening purposes is
recent data indicating a poor correlation between
Bayesian estimates of CAD likelihood and measurement
of CAC scores.
21 In addition, our study offers fresh
insight regarding the limitation of using stress testing to
screen for underlying disease among asymptomatic
patients.Thatis,theapplicationofSPECT imaginginour
patients yielded only 7% with ischemic responses, com-
pared to 70% with evidence of atherosclerosis by CAC
scanning, representing a wide differential of individuals
identiﬁed at risk. However, since the induction of
inducible myocardial ischemia has been shown to be
uncommon among patients with CAC scores\400,
18,19
an approach that ﬁrst uses CAC scanningmight serve asa
useful means of both narrowing and improving the
selectionofasymptomaticpatientsforsubsequentcardiac
stress testing. While the cost-effectiveness of such an
approach needs to be prospectively evaluated, a recent
study has suggested that the application of CAC scanning
has the potential to reduce health costs by virtue of
selectively concentrating downstream medical testing
among asymptomatic subjects with higher CAC scores.
22
CONCLUSIONS
Compared to asymptomatic volunteers, asymptom-
atic patients with comparably matched CAD risk factor
proﬁles contain substantially more individuals with
severe, clinically undetected atherosclerosis, as evi-
denced by CAC scores [1,000. This observation may
help explain the results of outcome studies that have
found overlapping cardiac event rates among asymp-
tomatic vs symptomatic patients referred for cardiac
stress testing. Prospective study is warranted to test the
use of CAC scanning as a cost-effective triaging tool for
the work-up of asymptomatic patients.
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